Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar;127(3):573-576.
doi: 10.1097/AOG.0000000000001289.

Association of Progestin Contraceptive Implant and Weight Gain

Affiliations
Randomized Controlled Trial

Association of Progestin Contraceptive Implant and Weight Gain

Maria F Gallo et al. Obstet Gynecol. 2016 Mar.

Abstract

Objective: To evaluate initiation of a two-rod, 150-mg levonorgestrel contraceptive implant on women's perceived and observed body weight.

Methods: We conducted a secondary analysis of data from an open, randomized controlled trial of adult, nonpregnant, human immunodeficiency virus-negative women attending a public clinic in Kingston, Jamaica, who were assigned to initiate implant use either immediately or after a 3-month delay. The primary objective of the parent study was to assess the effect of initiation of the implant on the frequency of condom use. We compared study arms during follow-up using one-sided χ tests for differences in perceived weight gain and loss, one-sided Wilcoxon-Mann-Whitney tests for median gain in measured weight, and logistic regression with generalized estimating equations for risk of gaining greater than 2 kg.

Results: From 2012 to 2014, women were assigned to the implant (n=208) or delay arm (n=206). At 3 months, more women in the implant arm (15.3%) reported perceived weight gain than in the control arm (4.3%) (P=.01). Despite differences in perception, the implant and control arms did not differ significantly in median weight gain at 1-month (0.0 kg and 0.0 kg, respectively; P=.44) and 3-month visits (0.5 kg and 0.0 kg, respectively; P=.27). Study arms did not differ in risk of gaining greater than 2 kg (odds ratio 0.9, 95% confidence interval 0.6-1.3).

Conclusion: We found no evidence of weight gain from short-term implant use. Through the power of the nocebo effect, the practice of counseling women to expect possible weight gain from initiating implant use could lead them to perceive weight gain even in its absence and contribute to the early discontinuation of this highly effective contraceptive method.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure

The authors did not report any potential conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Screening, enrollment, and follow-up. *Includes woman who declined to continue in study after declining to start implant. Gallo. Progestin Contraceptive Implant and Weight Gain. Obstet Gynecol 2016.

References

    1. FDA patient labeling: NEXPLANON (etonogestrel implant) radiopaque subdermal. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021529s007lbl.pdf. Retrieved October 9, 2015.
    1. FDA patient labeling: IMPLANON (etonogestrel implant). Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021529s004lbl.pdf. Retrieved October 9, 2015.
    1. Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safetyand efficacy of a single-rod etonogestrel implant (implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646–53. - PubMed
    1. Lusk AC, Mekary RA, Feskanich D, Willett WC. Bicycle riding, walking, and weight gain in premenopausal women. Arch Intern Med 2010;170:1050–6. - PMC - PubMed
    1. Colditz GA, Willett WC, Stampfer MJ, London SJ, Segal MR, Speizer FE. Patterns of weight change and their relation to diet in a cohort of healthy women. Am J Clin Nutr 1990;51:1100–5. - PubMed

Publication types

MeSH terms

LinkOut - more resources